The ability to discriminate between stereoisomers of alpha-tocopherol was studied in five patients with abetalipoproteinemia (ABL) because an impairment in secretion of apolipoprotein B-containing lipoproteins might impede the normally enhanced plasma transport of RRR-alpha-tocopherol. An oral dose containing 3.7 g of each 2R, 4'R,8'R-alpha-[5-C2H3]tocopheryl acetate (d3RRR-alpha-tocopheryl acetate) and 2RS,4'RS,8'RS-alpha-[5,7-(C2H3)2]tocopheryl acetate (d6 all rac-alpha-tocopheryl acetate) was administered, then the labeled and unlabeled alpha-tocopherol contents of plasma and red blood cells from multiple blood samples obtained at selected times up to 72 h following the dose were quantitated. ABL plasma contained about 1%-10% of the d3-RRR-alpha-tocopherol concentrations of normal subjects given only 150 mg of each isotope. Three of the patients discriminated between forms of alpha-tocopherol with ratios of RRR-/allrac-alpha-tocopherol > or = 1.8, similar to normals. These data suggest that the hepatic tocopherol binding protein is present and functional in ABL patients. Although two of the patients did not discriminate between stereoisomers of alpha-tocopherol, it is likely that this resulted from nearly a complete block in very low density lipoprotein (VLDL) secretion. Thus, the ability of ABL patients to absorb and transport orally administered vitamin E is markedly impaired and variable among patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0021-9150(94)90035-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Syndromic Retinitis Pigmentosa.
Prog Retin Eye Res
December 2024
Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; Department of Ophthalmology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Retinitis pigmentosa (RP) is a progressive inherited retinal dystrophy, characterized by the degeneration of photoreceptors, presenting as a rod-cone dystrophy. Approximately 20-30% of patients with RP also exhibit extra-ocular manifestations in the context of a syndrome. This manuscript discusses the broad spectrum of syndromes associated with RP, pathogenic mechanisms, clinical manifestations, differential diagnoses, clinical management approaches, and future perspectives.
View Article and Find Full Text PDFAbetalipoproteinemia with angioid streaks, choroidal neovascularization, atrophy, and extracellular deposits revealed by multimodal retinal imaging.
Ophthalmic Genet
December 2024
Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Article Synopsis
- - Abetalipoproteinemia (ABL) is a rare genetic disorder characterized by the absence of certain lipoproteins due to a defective triglyceride transfer protein, impacting the retina and leading to vision problems, including conditions resembling retinitis pigmentosa.
- - Multimodal retinal imaging was conducted on two ABL patients, revealing significant eye changes like choroidal neovascularization and deposits in the retina, alongside a range of vision loss.
- - The study suggests that mutations in the MTTP gene within the retina may contribute to ABL-related eye diseases, highlighting the importance of ongoing eye care for affected individuals, particularly to manage treatable conditions like choroidal neovascularization.
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population.
J Clin Lipidol
August 2024
Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute, Montréal, Québec, Canada (Drs Guay, Paquette, Gosse, Poulin, and Baass); Department of Medicine, Divisions of Experimental Medicine and Medical Biochemistry, McGill University, Montréal, Québec, Canada (Dr Baass). Electronic address:
Article Synopsis
- * Patients exhibit a range of symptoms, including neurological, hematological, and gastrointestinal issues, due to the lack of certain lipoproteins.
- * The report highlights four cases from a specific French-Canadian population, showing a higher-than-expected prevalence of a particular MTTP mutation, recommending early diagnosis and potential screening in the community.
A New Case of Abetalipoproteinemia Caused by Novel Compound Heterozygote Mutations in the MTTP Gene without Fat or Vitamin Malabsorption.
J Atheroscler Thromb
November 2024
Center for Preventive, Anti-aging and Regenerative Medicine, Fukuoka University Hospital.
Abetalipoproteinemia (ABL) is a rare disease characterized by extremely low apolipoprotein B (apoB)-containing lipoprotein levels, dietary fat, and fat-soluble vitamin malabsorption, leading to gastrointestinal, neuromuscular, and ophthalmological symptoms. We herein report a case of ABL with novel compound heterozygous mutations in the microsomal triglyceride transfer protein gene (c.1686_1687del [p.
View Article and Find Full Text PDFCarotenoids in familial hypobetalipoproteinemia disorders: Malabsorption in Caco2 cell models and severe deficiency in patients.
J Clin Lipidol
March 2024
Aix-Marseille Université, INRAE, INSERM, C2VN, Marseille, France (Dr Bordat, Halimi, Drs Vairo, Reboul). Electronic address:
Article Synopsis
- Familial hypobetalipoproteinemias (FHBL) are rare genetic disorders linked to lipid malabsorption, specifically abetalipoproteinemia (FHBL-SD1) and chylomicron retention disease (FHBL-SD3), caused by mutations in MTTP and SAR1B genes.* -
- This study aimed to assess the absorption and levels of carotenoids in patients with these conditions, revealing significant deficiencies in carotenoid levels compared to healthy controls; in lab models, carotenoid absorption was notably reduced.* -
- The findings suggest that despite treatment with fat-soluble vitamins, there's a continued loss in visual function, indicating that carotenoid supplementation could be crucial, and further research is
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!